190 related articles for article (PubMed ID: 8107261)
1. Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2.
Cannon P; Kim SH; Ulich C; Kim S
J Virol; 1994 Mar; 68(3):1993-7. PubMed ID: 8107261
[TBL] [Abstract][Full Text] [Related]
2. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
Murphy KM; Sweet MJ; Ross IL; Hume DA
J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of c-Fos in activated T lymphoid and monocytic cells by human immunodeficiency virus-1 Tat protein.
Gibellini D; Caputo A; Capitani S; La Placa M; Zauli G
Blood; 1997 Mar; 89(5):1654-64. PubMed ID: 9057648
[TBL] [Abstract][Full Text] [Related]
4. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function.
Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF
AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293
[TBL] [Abstract][Full Text] [Related]
5. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
Li XD; Moore B; Cloyd MW
Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
[TBL] [Abstract][Full Text] [Related]
6. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
8. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional effects of superinfection in HIV chronically infected T cells: studies in dually infected clones.
Kim JH; McLinden RJ; Mosca JD; Burke DS; Boswell RN; Birx DL; Redfield RR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(4):329-42. PubMed ID: 8673541
[TBL] [Abstract][Full Text] [Related]
10. The presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1.
Popik W; Pitha PM
J Virol; 1994 Mar; 68(3):1324-33. PubMed ID: 8107197
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat.
Cheng H; Tarnok J; Parks WP
J Virol; 1998 Aug; 72(8):6911-6. PubMed ID: 9658145
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected U1 cells by a long terminal repeat independent post-transcriptional mechanism.
Kinter AL; Biswas P; Alfano M; Justement JS; Mantelli B; Rizzi C; Gatti AR; Vicenzi E; Bressler P; Poli G
Mol Med; 2001 Oct; 7(10):668-78. PubMed ID: 11713366
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
J Virol; 2018 May; 92(9):. PubMed ID: 29491162
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells.
Rabbi MF; Finnegan A; Al-Harthi L; Song S; Roebuck KA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):321-31. PubMed ID: 9833740
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
Poli G; Orenstein JM; Kinter A; Folks TM; Fauci AS
Science; 1989 May; 244(4904):575-7. PubMed ID: 2470148
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus.
Simon G; Moog C; Obert G
Chem Biol Interact; 1994 Jun; 91(2-3):111-21. PubMed ID: 7514959
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency.
Butera ST; Roberts BD; Lam L; Hodge T; Folks TM
J Virol; 1994 Apr; 68(4):2726-30. PubMed ID: 7511177
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA.
Yang JY; Schwartz A; Henderson EE
AIDS Res Hum Retroviruses; 1993 Aug; 9(8):747-54. PubMed ID: 7692906
[TBL] [Abstract][Full Text] [Related]
19. Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells.
Duan L; Oakes JW; Ferraro A; Bagasra O; Pomerantz RJ
Virology; 1994 Mar; 199(2):474-8. PubMed ID: 8122376
[TBL] [Abstract][Full Text] [Related]
20. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses.
Chen BK; Saksela K; Andino R; Baltimore D
J Virol; 1994 Feb; 68(2):654-60. PubMed ID: 7507183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
